Skip to main content
Top
Published in: Rheumatology International 12/2010

01-11-2010 | Case Report

Systemic lupus erythematosus associated with vasculitic syndrome (Takayasu’s arteritis)

Authors: Zoraida Sachetto, Sandra R. M. Fernandes, Ana Paula T. Del Rio, Ibsen B. Coimbra, Manoel B. Bértolo, Lilian Tereza Lavras Costallat

Published in: Rheumatology International | Issue 12/2010

Login to get access

Abstract

A 43-year-old woman reported pain in the right hypochondrium, which had started 3 years before and had been worsening for the past few days. Claudication in the superior and inferior limbs, diffuse myalgia, dyspnea, precordialgia followed by dizziness and visual turbidity were added to the clinical picture. In the physical examination bilateral carotid bruit was observed, abdominal aorta murmur and the decrease of the right radial and left pedis pulses and arterial hypertension with difference in the diastolic pressure between limbs >10 mmHg was also observed. On cardiac catheterisation with aortography, right coronary with proximal parietal irregularities, slight pressure increase in right chambers and pulmonary artery, preserved left ventricle contractility, competent valves, carotid and subclavian partial obstruction, severe narrowing of the abdominal aorta below the diaphragm (80%) and right renal artery significant stenosis were observed. Takayasu’s arteritis (TA) diagnosis was established according to the ACR criteria based on the clinical symptomatology, on physical and image test findings. Two years later she presented malar rash, photosensitivity, nephropathy, leukopenia, lymphopenia and hemolytic anemia confirming the systemic lupus erythematosus (SLE) diagnosis. TA coexisting with SLE has rarely been reported.
Literature
2.
go back to reference Ito I (1977) Aortitis syndrome. Jpn Med J 2778:7–11(in Japanese) Ito I (1977) Aortitis syndrome. Jpn Med J 2778:7–11(in Japanese)
3.
go back to reference Riehl JL, Brown WJ (1965) Takayasu’s arteritis: an autoimmune disease. Arch Neurol 12:92–97PubMed Riehl JL, Brown WJ (1965) Takayasu’s arteritis: an autoimmune disease. Arch Neurol 12:92–97PubMed
4.
go back to reference Saxe P, Altman R (1992) Takayasu’s arteritis syndrome associated with systemic lupus erythematosus. Sem Arthritis Rheum 21(5):295–305CrossRef Saxe P, Altman R (1992) Takayasu’s arteritis syndrome associated with systemic lupus erythematosus. Sem Arthritis Rheum 21(5):295–305CrossRef
5.
go back to reference Igarashi T, Nagaoka S, Matsunaga K, Katoh K, Ishigatsubo Y, Tani K, Okubo T, Lie JT (1989) Aortitis syndrome (Takayasu’s arteritis) associated with systemic lupus erythematosus. J Rheumatol 16:1579–1584PubMed Igarashi T, Nagaoka S, Matsunaga K, Katoh K, Ishigatsubo Y, Tani K, Okubo T, Lie JT (1989) Aortitis syndrome (Takayasu’s arteritis) associated with systemic lupus erythematosus. J Rheumatol 16:1579–1584PubMed
6.
go back to reference Kameyama K, Kuramochi S, Ueda T, Kawada S, Tominaga N, Mimori T, Hata J (1999) Takayasu’s aortitis with dissection in systemic lupus erythematosus. Scand J Rheumatol 28:187–188CrossRefPubMed Kameyama K, Kuramochi S, Ueda T, Kawada S, Tominaga N, Mimori T, Hata J (1999) Takayasu’s aortitis with dissection in systemic lupus erythematosus. Scand J Rheumatol 28:187–188CrossRefPubMed
7.
go back to reference Sano N, Kitazawa K, Totsuka D, Kobayashi K, Honda H, Makimo Y, Shibata T, Sugisaki T (2002) A case of lupus nephritis with alteration of the glomerular basement membrane associated with Takayasu’s arteritis. Clin Nephrol 58(2):161–165PubMed Sano N, Kitazawa K, Totsuka D, Kobayashi K, Honda H, Makimo Y, Shibata T, Sugisaki T (2002) A case of lupus nephritis with alteration of the glomerular basement membrane associated with Takayasu’s arteritis. Clin Nephrol 58(2):161–165PubMed
8.
go back to reference Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed
9.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfiel NJ, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 25:1271–1277CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfiel NJ, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 25:1271–1277CrossRefPubMed
10.
go back to reference Nasu T (1962) Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan. Angiology 14:225–242CrossRef Nasu T (1962) Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan. Angiology 14:225–242CrossRef
Metadata
Title
Systemic lupus erythematosus associated with vasculitic syndrome (Takayasu’s arteritis)
Authors
Zoraida Sachetto
Sandra R. M. Fernandes
Ana Paula T. Del Rio
Ibsen B. Coimbra
Manoel B. Bértolo
Lilian Tereza Lavras Costallat
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1133-y

Other articles of this Issue 12/2010

Rheumatology International 12/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine